Incyte Corporation
INCY
$119.52
-$3.47-2.82%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.67B | 1.27B | 1.51B | 1.37B | 1.22B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.67B | 1.27B | 1.51B | 1.37B | 1.22B |
| Cost of Revenue | 621.91M | 620.43M | 732.55M | 605.59M | 573.68M |
| Gross Profit | 1.05B | 652.25M | 774.29M | 760.40M | 641.85M |
| SG&A Expenses | 350.72M | 327.06M | 388.97M | 328.29M | 330.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 972.63M | 947.49M | 1.12B | 933.87M | 903.94M |
| Operating Income | 701.41M | 325.19M | 385.32M | 432.11M | 311.59M |
| Income Before Tax | 751.51M | 343.60M | 389.94M | 482.31M | 558.01M |
| Income Tax Expenses | 165.91M | 40.27M | 90.66M | 58.14M | 153.01M |
| Earnings from Continuing Operations | 585.61M | 303.33M | 299.28M | 424.17M | 405.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 585.61M | 303.33M | 299.28M | 424.17M | 405.00M |
| EBIT | 701.41M | 325.19M | 385.32M | 432.11M | 311.59M |
| EBITDA | 727.89M | 348.99M | 409.31M | 456.13M | 334.51M |
| EPS Basic | 2.92 | 1.52 | 1.52 | 2.17 | 2.09 |
| Normalized Basic EPS | 2.32 | 1.13 | 1.33 | 1.47 | 1.10 |
| EPS Diluted | 2.81 | 1.47 | 1.46 | 2.11 | 2.04 |
| Normalized Diluted EPS | 2.23 | 1.09 | 1.28 | 1.43 | 1.08 |
| Average Basic Shares Outstanding | 200.38M | 199.34M | 197.44M | 195.67M | 194.00M |
| Average Diluted Shares Outstanding | 208.22M | 206.83M | 204.77M | 201.43M | 198.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |